BiomX Inc.
PHGE
$0.5086
$0.04068.68%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.24% | 72.24% | 50.79% | 58.27% | 17.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.33% | 61.49% | 35.05% | 72.34% | -2.64% |
| Operating Income | -28.33% | -61.49% | -35.05% | -72.34% | 2.64% |
| Income Before Tax | 55.79% | -164.30% | 222.08% | 169.90% | -172.57% |
| Income Tax Expenses | -80.00% | 200.00% | -- | -37.50% | -16.67% |
| Earnings from Continuing Operations | 55.80% | -164.31% | 221.96% | 169.74% | -172.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.80% | -164.31% | 221.96% | 169.74% | -172.39% |
| EBIT | -28.33% | -61.49% | -35.05% | -72.34% | 2.64% |
| EBITDA | -29.32% | -50.06% | -34.70% | -73.07% | 2.84% |
| EPS Basic | 88.08% | 12.01% | 123.73% | 161.46% | -40.48% |
| Normalized Basic EPS | 87.55% | 61.56% | 148.95% | 119.57% | -34.55% |
| EPS Diluted | 88.08% | 2.12% | 123.73% | -47.13% | -40.48% |
| Normalized Diluted EPS | 87.55% | 61.56% | 148.95% | 109.40% | -34.55% |
| Average Basic Shares Outstanding | 270.88% | 200.41% | 170.12% | 40.35% | 93.91% |
| Average Diluted Shares Outstanding | 270.88% | 200.41% | 170.12% | 192.06% | 93.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |